-

01:11:13 AM

IQV Stock News

IQV - IQVIA Holdings Inc

05/25/22 4:43 PM

NYSE : IQV

conferences

IQVIA CFO Ron Bruehlman to Speak at Jefferies Healthcare Conference on June 10, 2022

IQVIA Holdings Inc., announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Jefferies Healthcare Conference in New York City on Friday, June 10, 2022 at 11:30 a.m. ET. A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com.

RHEA-AI

neutral

04/27/22 7:00 AM

NYSE : IQV

IQVIA Reports First-Quarter 2022 Results

IQVIA Holdings Inc., a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended March 31, 2022. R&DS contracted backlog, including reimbursed expenses, grew 9.1 percent year-over-year to $25.3 billion as of March 31, 2022.

RHEA-AI

neutral

04/21/22 8:00 AM

NYSE : IQV

covid-19

Spending on U.S. Medicines Rose 12% in 2021 Due to COVID-19 Vaccines and Therapies, Says IQVIA Institute for Human Data Science

Spending on medicines in the United States, at estimated net manufacturer prices, reached $407 billion in 2021, up 12% over 2020, as COVID-19 vaccines and therapeutics became widely available and added $29 billion in related spending. That’ s according to a new U.S. Medicines Trends 2022 Report, released today by the IQVIA Institute for Human Data Science.

RHEA-AI

neutral

04/12/22 4:15 PM

NYSE : IQV

IQVIA to Announce First-Quarter 2022 Results on April 27, 2022

IQVIA Holdings Inc. will announce its first-quarter 2022 financial results before the market opens on Wednesday, April 27, 2022. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the...

RHEA-AI

neutral

03/30/22 6:00 PM

NYSE : IQV

IQVIA Selected to Support EMA’s DARWIN EU® Coordination Centre Initiative

IQVIA™, a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced that the European Medicines Agency has awarded a contract to Erasmus University Medical Center Rotterdam to provide analytics services to the DARWIN EU ® Coordination Centre which IQVIA was...

RHEA-AI

neutral

03/15/22 6:05 PM

NYSE : IQV

IQVIA Launches OCE+ To Deliver Enhanced AI-Driven Customer Engagement

IQVIA™ today announced the launch of OCE+, the first of several new advancements to its leading life science customer engagement platform. OCE+ adds IQVIA’ s Next Best recommendation engine– a daily workflow tool providing AI-driven recommendations for engaging healthcare professionals– to its Orchestrated Customer Engagement platform, providing enhanced...

RHEA-AI

very positive

03/14/22 9:00 AM

NYSE : IQV

management

IQVIA Appoints Costa Panagos President of Research & Development Solutions (R&DS)

IQVIA Holdings Inc., a leading global provider of advanced analytics, technology solutions, and contract services to the life sciences industry, today announced the appointment of Costa Panagos, to serve as president of its Research& Development Solutions business unit. Mr. Staub will remain with the company as a senior advisor to the CEO and continue...

RHEA-AI

neutral

03/03/22 4:15 PM

NYSE : IQV

conferences

IQVIA CFO to Speak at Barclays Global Healthcare Conference on March 16, 2022

IQVIA Holdings Inc., announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Barclays Global Healthcare Conference in Miami, FL on Wednesday, March 16, 2022 at 1:35 p.m. ET. A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com.

RHEA-AI

neutral

03/01/22 8:00 AM

NYSE : IQV

clinical trial

IQVIA selected to accelerate clinical development of VYVGART™ (efgartigimod alfa fcab) by argenx SE

IQVIA announced an agreement today with argenx SE. “We are excited to be working with argenx in a comprehensive way to support the development of their promising new treatment,” said Alistair Grenfell, president, Europe, Middle East, Africa and South Asia for IQVIA.“ IQVIA’ s end-to-end support will speed the clinical development and the commercial launch of new...

RHEA-AI

very positive

02/24/22 8:00 AM

NYSE : IQV

IQVIA Named Top CRO in 2021 WCG CenterWatch Independent Survey

IQVIA™, a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry was named the top CRO in Overall Reputation by clinical trial sites around the world in the 2021 WCG CenterWatch Global Site Relationship Benchmark Survey Report. The results were based on responses from investigators,...

RHEA-AI

neutral

1 2 3 4 5 6 7 Next

IQV Data

IndustryOffices of All Other Miscellaneous Health Practitioners
Websitewww.iqvia.com
CeoAri Bousbib
Security nameIQVIA Holdings Inc
Issue typecs
SectorHealth Care and Social Assistance
Sic code8731
Employees70000
Tags
- Health Services
- Services to the Health Industry
- Health Care and Social Assistance
- Offices of All Other Miscellaneous Health Practitioners
Address4820 Emperor Blvd
StateNorth Carolina
CityDurham
Zip27703-8426
CountryUS
Phone19199982000

About IQVIA Holdings Inc

IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility - enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 70,000 employees, IQVIA conducts operations in more than 100 countries.